CDSCO Panel Accepts BE Report, Tells Intas Pharma to Conduct Phase III Trial for Semaglutide Dr. Divya Colin28 May 2025 3:00 PM ISTNew Delhi: In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control...
CDSCO Panel Asks Regenix to Submit Additional Trial Data for Insulin Injection Approval Dr. Divya Colin23 May 2025 9:46 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has deferred its decision on the approval...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Torrent Pharmaceutical Gets CDSCO Panel Nod To study Semaglutide Tablets Dr. Divya Colin26 April 2025 6:15 PM ISTNew Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma Gets CDSCO Panel Nod To study Semaglutide solution for Injection Dr. Divya Colin19 April 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report of the antidiabetic drug Semaglutide solution for injection (synthetic origin) 0.25mg...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Alkem Laboratories Gets CDSCO Panel Nod To Study Semaglutide solution for injection Dr. Divya Colin25 Feb 2025 6:00 PM ISTNew Delhi: Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional under the...
CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Antidiabetic Drug Retatrutide study Dr. Divya Colin29 Dec 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
Lupin Gets CDSCO Panel Nod to Study Antidiabetic FDC Dr. Divya Colin1 Nov 2024 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eris Lifscience Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin29 Sept 2024 6:00 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) antidiabetic drug Dapagliflozin Propanediol Monohydrate...
Present difference of approved and proposed formulation: CDSCO tells Novo Nordisk's Semaglutide tablet Dr. Divya Colin27 Sept 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Novo Nordisk to import and market the antidiabetic drug Semaglutide tablets 1.5 mg,...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Empagliflozin plus Sitagliptin FDC Dr. Divya Colin28 Aug 2024 6:15 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
